297 related articles for article (PubMed ID: 11758683)
1. Cardiac manifestations in Fabry disease.
Linhart A; Lubanda JC; Palecek T; Bultas J; Karetová D; Ledvinová J; Elleder M; Aschermann M
J Inherit Metab Dis; 2001; 24 Suppl 2():75-83; discussion 65. PubMed ID: 11758683
[TBL] [Abstract][Full Text] [Related]
2. New insights in cardiac structural changes in patients with Fabry's disease.
Linhart A; Palecek T; Bultas J; Ferguson JJ; Hrudová J; Karetová D; Zeman J; Ledvinová J; Poupetová H; Elleder M; Aschermann M
Am Heart J; 2000 Jun; 139(6):1101-8. PubMed ID: 10827394
[TBL] [Abstract][Full Text] [Related]
3. Cardiac involvement in Fabry disease.
Linhart A; Magage S; Palecek T; Bultas J
Acta Paediatr Suppl; 2002; 91(439):15-20. PubMed ID: 12572837
[TBL] [Abstract][Full Text] [Related]
4. Anderson-Fabry disease: a multiorgan disease.
Tuttolomondo A; Pecoraro R; Simonetta I; Miceli S; Pinto A; Licata G
Curr Pharm Des; 2013; 19(33):5974-96. PubMed ID: 23448451
[TBL] [Abstract][Full Text] [Related]
5. Terminal stage cardiac findings in patients with cardiac Fabry disease: an electrocardiographic, echocardiographic, and autopsy study.
Takenaka T; Teraguchi H; Yoshida A; Taguchi S; Ninomiya K; Umekita Y; Yoshida H; Horinouchi M; Tabata K; Yonezawa S; Yoshimitsu M; Higuchi K; Nakao S; Anan R; Minagoe S; Tei C
J Cardiol; 2008 Feb; 51(1):50-9. PubMed ID: 18522775
[TBL] [Abstract][Full Text] [Related]
6. Early diastolic mitral annular velocity and color M-mode flow propagation velocity in the evaluation of left ventricular diastolic function in patients with Fabry disease.
Palecek T; Linhart A; Lubanda JC; Magage S; Karetova D; Bultas J; Aschermann M
Heart Vessels; 2006 Jan; 21(1):13-9. PubMed ID: 16440143
[TBL] [Abstract][Full Text] [Related]
7. Fabry disease: focus on cardiac manifestations and molecular mechanisms.
Perrot A; Osterziel KJ; Beck M; Dietz R; Kampmann C
Herz; 2002 Nov; 27(7):699-702. PubMed ID: 12439642
[TBL] [Abstract][Full Text] [Related]
8. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.
Poulsen SH
Dan Med Bull; 2001 Nov; 48(4):199-210. PubMed ID: 11767125
[TBL] [Abstract][Full Text] [Related]
9. Fabry disease: a functional and anatomical study of cardiac manifestations in 20 hemizygous male patients.
Senechal M; Germain DP
Clin Genet; 2003 Jan; 63(1):46-52. PubMed ID: 12519371
[TBL] [Abstract][Full Text] [Related]
10. Cardiac manifestations of Anderson-Fabry disease in heterozygous females.
Kampmann C; Baehner F; Whybra C; Martin C; Wiethoff CM; Ries M; Gal A; Beck M
J Am Coll Cardiol; 2002 Nov; 40(9):1668-74. PubMed ID: 12427421
[TBL] [Abstract][Full Text] [Related]
11. Enzyme replacement therapy with agalsidase beta improves cardiac involvement in Fabry's disease.
Spinelli L; Pisani A; Sabbatini M; Petretta M; Andreucci MV; Procaccini D; Lo Surdo N; Federico S; Cianciaruso B
Clin Genet; 2004 Aug; 66(2):158-65. PubMed ID: 15253767
[TBL] [Abstract][Full Text] [Related]
12. Detection of preclinical left ventricular dysfunction in Fabry disease: the contribution of tissue Doppler.
Fiuza M; Avó LB; Oliveira EI; Gonçalves S; Lopes MG
Rev Port Cardiol; 2006 Jun; 25(6):613-37. PubMed ID: 17019980
[TBL] [Abstract][Full Text] [Related]
13. [Cardiac manifestation of Fabry's disease: current knowledge].
Palecek T; Lubanda JC; Magage S; Karetová D; Bultas J; Linhart A
Vnitr Lek; 2004 Nov; 50(11):846-51. PubMed ID: 15648965
[TBL] [Abstract][Full Text] [Related]
14. The heart in Anderson Fabry disease.
Kampmann C; Wiethoff CM; Perrot A; Beck M; Dietz R; Osterziel KJ
Z Kardiol; 2002 Oct; 91(10):786-95. PubMed ID: 12395219
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular manifestations in Fabry disease: a clinical and echocardiographic study.
Sadick N; Thomas L
Heart Lung Circ; 2007 Jun; 16(3):200-6. PubMed ID: 17452128
[TBL] [Abstract][Full Text] [Related]
16. Fabry disease: cardiac manifestations and therapeutic options.
Pierre-Louis B; Kumar A; Frishman WH
Cardiol Rev; 2009; 17(1):31-5. PubMed ID: 19092368
[TBL] [Abstract][Full Text] [Related]
17. [Cardiac manifestations in Fabry disease].
Lappegård KT; Aass H
Tidsskr Nor Laegeforen; 2000 Aug; 120(20):2395-6. PubMed ID: 11475223
[TBL] [Abstract][Full Text] [Related]
18. [Cardiological follow-up in patients with Fabry disease].
Pieruzzi F; Pieroni M; Chimenti C; Frustaci A; Sarais C; Cecchi F;
G Ital Cardiol (Rome); 2010; 11(7-8):566-72. PubMed ID: 21033333
[TBL] [Abstract][Full Text] [Related]
19. Left atrial enlargement and reduced atrial compliance occurs early in Fabry cardiomyopathy.
Boyd AC; Lo Q; Devine K; Tchan MC; Sillence DO; Sadick N; Richards DA; Thomas L
J Am Soc Echocardiogr; 2013 Dec; 26(12):1415-23. PubMed ID: 24094560
[TBL] [Abstract][Full Text] [Related]
20. Symptomatic exercise-induced left ventricular outflow tract obstruction without left ventricular hypertrophy.
Alhaj EK; Kim B; Cantales D; Uretsky S; Chaudhry FA; Sherrid MV
J Am Soc Echocardiogr; 2013 May; 26(5):556-65. PubMed ID: 23534983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
